You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Government & Policy Articles
Popular Government & Policy Articles
Highly Recommended Government & Policy Articles
Send a link to this page to your friends and colleagues.
On November 20, 2000, Abbott Laboratories of Bedford, Massachusetts announced it had received U.S. Food and Drug Administration marketing clearance for its Sof-Tact. This diabetes management system, according to Abbott, is the first automated glucose monitor to offer lancing, blood collection and glucose testing with a single press of a button.
The Sof-Tact uses a unique vacuum mechanism that holds the skin in place while an integrated apparatus lances the skin. The blood is automatically transferred to a low-volume bio-sensor strip, and a blood glucose test result is delivered in 20 seconds.
According to Abbott, Sof-Tact allows samples to be drawn from less sensitive areas of the body such as the forearm or upper arm. The device also employs new strip technology, which requires less blood. This eliminates many user-generated errors, providing for a level of consistency and accuracy unmatched by other manual methodologies.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.